Press release
Beta Blockers Market, Size, Share, Outlook-2030
Beta Blockers Market, Size, Share, Outlook, DataM Intelligence-2030||
Beta Blockers Market is Expected to reach at a high CAGR 4.29 % during the forecast period (2022-2029).
Beta blockers, also known as beta-adrenergic blocking agents, reduce blood pressure. It is used to prevent, deal with or improve symptoms in people who've abnormal coronary heart rhythm (arrhythmia), coronary heart failure, Chest ache (angina), coronary heart assaults, Migraine, sure varieties of tremors. It works by blocking the effects of the hormone epinephrine, also known as adrenaline.
Download Free Sample: https://www.datamintelligence.com/download-sample/beta-blockers-market
Market Dynamics:
The increasing prevalence of hypertension in the geriatric population is expected to drive market growth.
Older adults are generally undertreated for high blood pressure, despite having the highest prevalence of hypertension and the highest risk of CV morbidity and mortality (BP).
Hypertension is a major modifiable risk factor for cardiovascular disease (CVD), and its prevalence and severity rise with age.
View Full Report: https://www.datamintelligence.com/research-report/beta-blockers-market
Segment Analysis:
1. By Type
• Nonselective Agents*
o Propranolol (Inderal)
o Nadolol (CorGard)
o Pindolol (Visken)
o Penbutolol (Levatol)
o Sotalol (Betapace)
o Others
o Introduction
o Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
• Selective Agents
o Atenolol
o Betaxolol
o Esmolol
o Nebivolol
o Others
2. By Indication
• Angina Pectoris
• Heart Failure
• High Blood Pressure
• Others
3. By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Competitive Landscape
Major key players in the beta blockers market are Pfizer, Neon Healthcare, Novartis, Mercury Laboratories Ltd., Bayer HealthCare Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Midas Pharma GmbH, Global Calcium PVT LTD, Baxter and AbbVie Inc.
Trending Topics
Pet Food Market: https://www.datamintelligence.com/research-report/pet-food-market
Organic Pet Food Market: https://www.datamintelligence.com/research-report/organic-pet-food-market
Freeze-Dried Pet Food Market: https://www.datamintelligence.com/research-report/freeze-dried-pet-food-market
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park,
Industrial Development Area, Uppal,
Hyderabad, Telangana 500039
DataM Intelligence 4Market Research is a market intelligence platform that gives access to
syndicated, customized reports and consulting to its clients in one place. As a firm with rich
experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages, among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates ease access and custom personalization to research and markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta Blockers Market, Size, Share, Outlook-2030 here
News-ID: 2836129 • Views: …
More Releases from DataM Intelligence 4Market Research
Oral Mucositis Market Poised for Strong Growth Driven by Rising Cancer Therapies …
Market Size and Growth:
The Oral Mucositis Market reached US$ 1.62 billion in 2023 and is expected to reach US$ 2.30 billion by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.
Oral Mucositis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
Global Medical Second Opinion Market Soars as Patients Seek Accurate Diagnoses & …
Market Size and Growth:
The Global Medical Second Opinion Market size reached USD 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to USD 12,701.8 million by 2031. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period 2024-2031.
Medical Second Opinion Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and…
Global Cancer Molecular Diagnostics Market Set for Strong Growth with Breakthrou …
Market Overview:
The Global Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031.
Cancer Molecular Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…
Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalenc …
Market Size and Growth:
The Gout Therapeutics Market size was valued USD 1.9 billion in 2021 and is estimated to reach USD 4.1 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).
Gout Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
